# Heparin Sodium

NDC: 63323-523
Generic name: HEPARIN SODIUM
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170824

FDA application: NDA017029

## Active ingredients

- HEPARIN SODIUM: 10000 [USP'U]/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-523"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-523
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb1c1e7a-c9ca-4a07-8833-e45ce436d287